DE69230106T2 - Peptid-antigene bestehend aus multi-determinanten, die die t-helfer lymphozyten-antwort gegen hiv in einem weiten bereich von betroffenen menschen stimulieren - Google Patents

Peptid-antigene bestehend aus multi-determinanten, die die t-helfer lymphozyten-antwort gegen hiv in einem weiten bereich von betroffenen menschen stimulieren

Info

Publication number
DE69230106T2
DE69230106T2 DE69230106T DE69230106T DE69230106T2 DE 69230106 T2 DE69230106 T2 DE 69230106T2 DE 69230106 T DE69230106 T DE 69230106T DE 69230106 T DE69230106 T DE 69230106T DE 69230106 T2 DE69230106 T2 DE 69230106T2
Authority
DE
Germany
Prior art keywords
hiv
wide range
helper
stimulate
antigene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69230106T
Other languages
English (en)
Other versions
DE69230106D1 (de
Inventor
Jay Berzofsky
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
Original Assignee
US Department of Health and Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Health and Human Services filed Critical US Department of Health and Human Services
Publication of DE69230106D1 publication Critical patent/DE69230106D1/de
Application granted granted Critical
Publication of DE69230106T2 publication Critical patent/DE69230106T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE69230106T 1991-08-29 1992-08-31 Peptid-antigene bestehend aus multi-determinanten, die die t-helfer lymphozyten-antwort gegen hiv in einem weiten bereich von betroffenen menschen stimulieren Expired - Lifetime DE69230106T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75199891A 1991-08-29 1991-08-29
PCT/US1992/007422 WO1993004697A1 (en) 1991-08-29 1992-08-31 Multideterminant peptide antigens that stimulate helper t lymphocyte response to hiv in a range of human subjects

Publications (2)

Publication Number Publication Date
DE69230106D1 DE69230106D1 (de) 1999-11-11
DE69230106T2 true DE69230106T2 (de) 2000-03-30

Family

ID=25024412

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69230106T Expired - Lifetime DE69230106T2 (de) 1991-08-29 1992-08-31 Peptid-antigene bestehend aus multi-determinanten, die die t-helfer lymphozyten-antwort gegen hiv in einem weiten bereich von betroffenen menschen stimulieren

Country Status (9)

Country Link
EP (1) EP0601108B1 (de)
JP (1) JPH07501516A (de)
AT (1) ATE185275T1 (de)
AU (1) AU665023B2 (de)
CA (1) CA2114849C (de)
DE (1) DE69230106T2 (de)
DK (1) DK0601108T3 (de)
ES (1) ES2257733T3 (de)
WO (1) WO1993004697A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6294322B1 (en) 1988-01-26 2001-09-25 The United States Of America As Represented By The Department Of Health And Human Services Multideterminant peptides that elicit helper T-lymphocyte cytotoxic T-lymphocyte and neutralizing antibody responses against HIV-1
US5128319A (en) 1987-08-28 1992-07-07 Board Of Regents, The University Of Texas System Prophylaxis and therapy of acquired immunodeficiency syndrome
US6210873B1 (en) 1987-08-28 2001-04-03 Board Of Regents, The University Of Texas System Methods and compositions for the priming of specific cytotoxic T-lymphocyte response
WO1995003067A1 (en) * 1993-07-21 1995-02-02 Khavinson Vladimir Khatskelevi Pharmaceutical with immunomodulating activity
US5603933A (en) * 1993-08-31 1997-02-18 Board Of Regents, The University Of Texas CD4 peptides for binding to viral envelope proteins
US5972339A (en) * 1997-11-13 1999-10-26 The General Hospital Corporation Method of eliciting anti-HIV-1 helper T cell responses
BR0108210A (pt) 2000-02-04 2002-10-22 Univ Duke Vacina contra o vìrus da imunodeficiência humana
CN110349627B (zh) * 2019-06-27 2021-08-27 杭州纽安津生物科技有限公司 多肽疫苗序列的设计方法及其自动化设计产品

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU592258B2 (en) * 1986-12-30 1990-01-04 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Synthetic peptides which induce cellular immunity to the aids virus and aids viral proteins
US5030449A (en) * 1988-07-21 1991-07-09 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Synthetic vaccine against AIDS virus
EP0279688B1 (de) * 1987-02-20 1997-04-16 Genentech, Inc. Verfahren und Zubereitungen für die Verwendung von HIV-env-Polypeptiden und Antikörpern
WO1989002277A2 (en) * 1987-08-28 1989-03-23 Board Of Regents, The University Of Texas System Prophylaxis and therapy of acquired immunodeficiency syndrome
US5128319A (en) * 1987-08-28 1992-07-07 Board Of Regents, The University Of Texas System Prophylaxis and therapy of acquired immunodeficiency syndrome
ATE128716T1 (de) * 1987-11-24 1995-10-15 Abbott Lab Hiv-peptide und methoden für den nachweis von hiv.
CA1341285C (en) * 1988-02-12 2001-08-14 Chang Yi Wang Synthetic peptides for the detection of antibodies to hiv gp120 envelope protein for diagnosis of aids and pre-aids conditions and as vaccines
US4943628A (en) * 1988-06-13 1990-07-24 Ortho Pharmaceutical Corporation HIV peptide-inducted T cell stimulation
CA2003383A1 (en) * 1988-11-23 1990-05-23 Sushil G. Devare Synthetic dna derived recombinant hiv antigens
EP0527789A1 (de) * 1990-04-03 1993-02-24 Genentech, Inc. Hiv-hüllpolypeptide
WO1992005800A1 (en) * 1990-09-27 1992-04-16 Syntello Vaccin Development Kb Peptides for use in vaccination and induction of neutralizing antibodies against human immunodeficiency virus

Also Published As

Publication number Publication date
JPH07501516A (ja) 1995-02-16
DK0601108T3 (da) 2000-04-17
AU665023B2 (en) 1995-12-14
WO1993004697A1 (en) 1993-03-18
ATE185275T1 (de) 1999-10-15
CA2114849A1 (en) 1993-03-18
EP0601108A1 (de) 1994-06-15
DE69230106D1 (de) 1999-11-11
ES2257733T3 (es) 2006-08-01
EP0601108A4 (en) 1997-03-19
CA2114849C (en) 2007-04-24
EP0601108B1 (de) 1999-10-06
AU2569392A (en) 1993-04-05

Similar Documents

Publication Publication Date Title
GB2255093A (en) Hiv-1 core protein fragments
ES2063515T3 (es) Ifn-alfa o-glucosilados.
DE69028671T2 (de) Löslisches extrazellulares Fragment des menschlischen IFN-beta 2/IL-6-Rezeptors, seine Herstellung und diesen Fragment enthaltende pharmazeutische Mischung
DE3883985T2 (de) Ärztliches instrument und dessen herstellung.
EP0909814A3 (de) Verwendung von Proteinkinasen zur Diagnose und Behandlung der Alzheimer'schen Krankheit
DE69327307D1 (de) Herstellung von antigenen und impfstoffen vom mysterie-disease-virus, antigene und erworbene impfstoffe zur verhinderung dieser krankheit
BR9004922A (pt) Protese de valvula cardiaca
ATE444360T1 (de) T-zell epitopen von den wichtigsten allergene von dermatophagoides (hausmilbe)
DE69015866D1 (de) Blutbeutel und Anschlusstück des Blutsammelschlauches an den Blutbeutel.
DE69230106D1 (de) Peptid-antigene bestehend aus multi-determinanten, die die t-helfer lymphozyten-antwort gegen hiv in einem weiten bereich von betroffenen menschen stimulieren
DE3685917D1 (de) Peptid-zusammensetzung fuer die herstellung von malaria-impfstoff, sowie fuer die vorbereitung von diagnostischen einzelteilen fuer den nachweis von malaria-aehnlichen krankheiten.
DE3879968D1 (de) Malaria-impfstoff aus copolymerem protein.
MX9101275A (es) Proteina gp160 del virus de inmunodeficiencia humana y composiciones para vacuna que contiene a la misma o a su derivado
ES2062067T3 (es) Procedimiento de preparacion de alfa, omega-diaminas alifaticas, compuestos nuevos y su empleo en tincion capilar.
DE69115393D1 (de) Nicht-invasives verfahren zur bestimmung der bewegung der halswirbelsäule
RU94002476A (ru) Лекарственное средство
IT8948431A0 (it) Allergeni modificati chimicamente e procedimento per la loro preparazione
ITMI910658A0 (it) N-(4,5-diidrossi-e 4,5,8-triidrossi-9,10-diidro-9,10-diosso-2- antracen-il)carbonil) amminoacidi utilizzabili nella terapia delle affezioni osteoarticolari
DE68926245T2 (de) Nachweis der basismembrankomponenten, diagnose von krebs und sonstigen krankheiten
IT8919524A0 (it) Derivati dal 1 arilsolfonil 2 piperidone, loro procedimento di preparazione e loro impiego come farmaci.
ES2176363T3 (es) Peptidos de la proteina gag del vih, su preparacion y su uso.
SE8803062L (sv) Sekvensiella polypeptider med immunologisk aktivitet
DE69122850T2 (de) Konformationsepitope des humanen Immundefizienzvirus-Hüllprotein-gp120
IT8721945A0 (it) Procedimento per la profumazione di libri, dispositivo per l'attuazione di detto procedimento
SE8802323D0 (sv) 8alfa-acylaminoergoline, its preparation and pharmaceutical compositions containing it

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
R071 Expiry of right

Ref document number: 601108

Country of ref document: EP